Skip to NavigationSkip to content

News

Armo BioSciences only went public in January but it has already been snapped up by Eli Lilly for $1.6 billion. This marks a 68% premium on the...
At the request of the FDA, The US Department of Justice has launched legal action seeking to shut down stem cell clinics in California and Florida...
Lodo Therapeutics' form of drug discovery has managed to catch the eye of Roche’s subsidiary, Genentech, which has put down an undisclosed upfront...
Novartis payment to President Trump’s personal lawyer, Michael Cohen, had seemed fairly odd from the beginning – with many asking the same question,...
The revamped edition focuses on three key therapeutic areas: oncology, cardiovascular disease, and central nervous system disorders.
Simon Dingemans has been Chief Financial Officer at GSK since 2011 but has now chosen to retire from the position this time next year.
In the latest attempt to reverse its ailing fortunes and distance itself from its polluted brand, Canadian pharma firm Valeant has announced that...
Researchers from the University of Manchester’s Centre for Dermatology Research have made a breakthrough towards the holy grail of the cosmetic...
Faron Pharmaceuticals has seen its share price plummet by more than 80% after it emerged that its drug traumakine failed to meet its primary...
Novartis has suddenly found itself embroiled in the Stormy Daniels affair, after the lawyer representing her, Michael Avenatti, included the Basel-...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches